Article
T-cell Line for HIV Drug Screening Using EGFP as a Quantitative Marker of HIV-1 Replication
1 Jan 2006
Abstract excerpt
The rapid increase of viral strains that are resistant to the currently available antiretroviral drugs is a threat to the success of current human immunodeficiency virus type 1 (HIV-1) treatment and emphasizes the importance of developing novel anti-HIV-1 compounds. To improve the current abilities to screen for novel HIV-1 inhibitors, here we introduce a T-cell-based reporter cell line (JLTRG-RS) that expresses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
